login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
HARMONY BIOSCIENCES HOLDINGS (HRMY) Stock News
USA
- NASDAQ:HRMY -
US4131971040
-
Common Stock
34.03
USD
-0.26 (-0.76%)
Last: 11/14/2025, 8:00:01 PM
34.03
USD
0 (0%)
After Hours:
11/14/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
HRMY Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Appears Undervalued with Strong Fundamentals
12 days ago - By: Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Beats Q3 2025 Estimates Despite Muted Market Reaction
12 days ago - By: Zacks Investment Research
- Mentions:
LFCR
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates
13 days ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
13 days ago - By: Benzinga
- Mentions:
KURA
SEE
FOLD
UPST
...
Earnings Scheduled For November 4, 2025
13 days ago - By: Benzinga
Earnings Preview For Harmony Biosciences
18 days ago - By: Zacks Investment Research
- Mentions:
JAZZ
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q3 Earnings Expected to Decline
19 days ago - By: Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY): A Prime GARP Investment with Strong Growth and a Reasonable Price
25 days ago - By: Stocktwits
- Mentions:
AVUS
SFLO
Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial?
25 days ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
2 months ago - By: Stocktwits
- Mentions:
IWMW
AOR
HMC
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
2 months ago - By: Investor's Business Daily
Harmony Biosciences Whiffs In 'Undruggable' Genetic Disease; Shares Tumble
2 months ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
3 months ago - By: Yahoo Finance
Harmony Biosciences Holdings, Inc. (HRMY) Expands WAKIX With FDA Nod for Prader-Willi
3 months ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
3 months ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
3 months ago - By: Zacks Investment Research
- Mentions:
CRBP
CGC
TLRY
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
3 months ago - By: Zacks Investment Research
- Mentions:
GOSS
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
3 months ago - By: Harmony Biosciences Holdings, Inc.
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025
3 months ago - By: Yahoo Finance
- Mentions:
VZ
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
Please enable JavaScript to continue using this application.